Exelixis Inc (NASDAQ:EXEL)

17.69
Delayed Data
As of May 24
 -0.06 / -0.34%
Today’s Change
15.50
Today|||52-Week Range
24.69
-3.23%
Year-to-Date
3 Stocks That Could Make You a Fortune Over the Next 10 Years
May 21 / MotleyFool.com - Paid Partner Content
Buying These 3 Stocks Could Be the Smartest Investing Move You Ever Make
May 17 / MotleyFool.com - Paid Partner Content
Can This Cancer Stock Maintain Its Momentum?
May 18 / MotleyFool.com - Paid Partner Content
Exelixis (EXEL) Q1 2022 Earnings Call Transcript
May 11 / MotleyFool.com - Paid Partner Content
Is SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now?
May 18 / Zacks.com - Paid Partner Content
Exelixis (EXEL) Q1 Earnings Beat, Revenues Miss Estimates
May 11 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close17.75
Today’s open17.91
Day’s range17.52 - 17.74
Volume62,934
Average volume (3 months)2,415,415
Market cap$5.7B
Data as of 4:00pm ET, 05/24/2022

Growth & Valuation

Earnings growth (last year)+102.37%
Earnings growth (this year)+20.72%
Earnings growth (next 5 years)+37.33%
Revenue growth (last year)+45.31%
P/E ratio19.1
Price/Sales4.11
Price/Book2.56

Competitors

 Today’s
change
Today’s
% change
MEDPMedpace Holdings Inc-0.56-0.42%
SYNHSyneos Health Inc-0.92-1.29%
ADPTAdaptive Biotechnolo...-0.47-5.95%
FGENFibroGen Inc-0.22-2.51%
Data as of 4:00pm ET, 05/24/2022

Financials

Next reporting dateAugust 3, 2022
EPS forecast (this quarter)$0.21
Annual revenue (last year)$1.4B
Annual profit (last year)$231.1M
Net profit margin16.10%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Alameda, California

Forecasts